Stryker’s Endoscopy Division Acquires Ivy sports-medicine
Stryker’s Endoscopy division acquired Ivy sports-medicine, enabling Stryker to offer a complete meniscal platform. Sep 01, 2016
Implanet Receives U.S. Patent for Jazz Spinal Technology
Implanet was granted a U.S. patent protecting the JAZZ® technology platform through 2032. Aug 30, 2016
Bioretec Activa Implants Reach 100,000-Patient Milestone
Bioretec’s Activa implants, designed for fracture repair, arthrodesis, etc., reached the milestone of 100,000 patients operated over 10 years, with a complication rate of 0.01%. Aug 30, 2016
Ferring Acquires Rights to Seikagaku Treatment for Herniated Disc
Ferring Pharmaceuticals acquired exclusive development and commercialization rights to Seikagaku’s SI-6603 injectable condoliase, a potential treatment for lumbar disc herniation, for up to US $95.0MM in upfront cash plus milestone payments. Aug 29, 2016
KFx Medical Awarded Patent for Self-Punching Orthopaedic Anchors
KFx Medical was awarded a third patent (U.S. Patent No. 9,414,835) for self-punching/self-tapping orthopaedic anchors, designed to eliminate the need to drill a hole prior to insertion. Aug 26, 2016
Life Spine Completes Initial Cases with SENTRY Lateral Plate
Life Spine announced successful completion of initial cases using the SENTRY™ Lateral Plate. Full launch will occur by the end of 2016. Aug 26, 2016
Tyber Medical Launches a Lateral Plate
Tyber Medical commenced commercial launch of a low profile lateral plating system. Aug 24, 2016
CTL Medical Enters GSA Partnership with Firehouse Medical
CTL Medical entered into a General Services Administration partnership with Firehouse Medical to sell spinal implants and devices to the U.S. government. Aug 24, 2016
FDA Clearance for New Sizes of Amedica’s Valeo II LLIF Device
Amedica received FDA 510(k) clearance for expanded sizes of the Valeo® II Lateral Lumbar interbody fusion device. Aug 24, 2016
2-Year Results from SI-BONE iFuse INSITE Trial
Two-year results from a randomized, controlled trial in the management of sacroiliac joint dysfunction revealed that SI-BONE’s iFuse yielded more rapid improvements in pain, disability and quality of life vs. non-surgical treatment. Aug 24, 2016
